Marialuisa Longo | Orthodontics | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Marialuisa Longo | Orthodontics | Best Researcher Award

University of Bari “Aldo Moro” | Italy

Dr. Marialuisa Longo is a dedicated academic and researcher at the University of Bari “Aldo Moro,” specializing in orthodontics and dentistry. Her work integrates both clinical expertise and research-driven innovation, with a strong commitment to enhancing patient care through advanced methodologies and digital tools. Through her contributions, she has helped bridge the gap between traditional orthodontic practices and modern technological approaches. Her scholarly output includes several peer-reviewed journal publications that highlight her impact on improving treatment effectiveness and patient experience. She is an active member of professional organizations such as SIDO, SUSO, and AIDOR, which reflects her commitment to professional development and collaborative knowledge exchange. Dr. Longo’s research and academic endeavors exemplify a balance between theory and practice, making her contributions valuable to both scientific advancement and clinical applications. With a clear vision of advancing dental sciences, she continues to inspire innovation and quality care in orthodontics.

Profile

ORCID

Education

Dr. Marialuisa Longo pursued her academic journey at the University of Bari “Aldo Moro,” where she developed her expertise in dentistry and orthodontics. Her education was marked by rigorous training in both theoretical knowledge and practical applications, equipping her with the skills necessary to excel in academic and clinical practice. The curriculum emphasized an interdisciplinary approach, fostering her understanding of advanced orthodontic methodologies, patient-centered care, and integration of emerging technologies into dental practice. Throughout her education, Dr. Longo was actively involved in research-oriented learning, which laid the foundation for her later scholarly contributions. She demonstrated a strong aptitude for critical thinking, clinical problem-solving, and innovation in dental sciences. Her academic preparation provided her with a comprehensive understanding of the complexities of oral health and orthodontics, shaping her career as both a practitioner and a researcher. The combination of scientific rigor and clinical immersion during her education defines her academic excellence.

Experience

Dr. Marialuisa Longo has cultivated her professional experience at the University of Bari “Aldo Moro,” where she combines academic research, teaching, and clinical practice in dentistry and orthodontics. Her professional journey reflects a dedication to advancing orthodontic treatment through innovative techniques and interdisciplinary collaborations. She has authored several peer-reviewed journal articles that demonstrate her ability to translate scientific knowledge into practical solutions. Her work emphasizes enhancing treatment effectiveness, patient comfort, and the integration of digital tools into modern orthodontic practice. Through her memberships in professional organizations such as SIDO, SUSO, and AIDOR, Dr. Longo engages with the wider dental community, ensuring her work remains informed by global standards and contemporary developments. Her experience is also characterized by mentoring and contributing to the academic development of students, fostering the next generation of dental professionals. The combination of clinical, research, and academic experience makes her a versatile and impactful contributor to dentistry.

Awards and Honors

Dr. Marialuisa Longo’s academic and professional achievements reflect recognition of her contributions to the field of dentistry and orthodontics. Her published research in peer-reviewed journals showcases her commitment to advancing knowledge and improving clinical practice, earning respect within the scientific community. As an active member of prestigious professional associations such as SIDO, SUSO, and AIDOR, she has gained acknowledgment for her engagement in collaborative research and clinical excellence. While her career is still evolving, the quality and significance of her work demonstrate award-worthy accomplishments in integrating innovative technologies with orthodontic care. Her recognition extends beyond publications to her role as a contributor to the academic and clinical missions of the University of Bari “Aldo Moro.” Her ongoing commitment to excellence, coupled with her dedication to patient-focused research and practice, positions her as a promising and deserving candidate for professional honors and awards within the dental sciences.

Research Focus

Dr. Marialuisa Longo’s research focuses on orthodontics and the development of innovative strategies that improve patient care and clinical efficiency. She is particularly interested in integrating digital tools and advanced technologies into traditional orthodontic practices, making treatments more precise, effective, and comfortable for patients. Her published works highlight her contributions to bridging the gap between clinical methodologies and scientific research, ensuring that innovation is directly applied in real-world practice. By collaborating across disciplines within the University of Bari “Aldo Moro,” she contributes to the adoption of evidence-based techniques that transform orthodontic outcomes. Her focus also extends to improving patient experience, emphasizing comfort and efficiency in treatment protocols. Through active involvement in professional associations, she continually aligns her research with the evolving standards of global dentistry. Dr. Longo’s research represents a blend of academic rigor and clinical practicality, aimed at advancing orthodontics through innovation and patient-centered approaches.

Conclusion

Dr. Marialuisa Longo exemplifies the spirit of innovation and dedication in orthodontics through her research, clinical practice, and academic contributions at the University of Bari “Aldo Moro,” where she continuously strives to integrate modern technologies, enhance patient care, and contribute to the global advancement of dentistry, making her an outstanding candidate for the Best Researcher Award.

Muhammad Saeed | Clinical Research | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Muhammad Saeed | Clinical Research | Best Researcher Award

PRX Research | United States

Dr. Muhammad  Saeed is a highly accomplished physician and clinical research leader with extensive expertise in advancing medical innovation. He has dedicated his career to bridging clinical practice and research, focusing on infectious diseases, chronic illnesses, and novel therapeutics. With a foundation in medicine from Dow Medical College, he progressed to leadership positions in multiple U.S.-based clinical research centers, where he directed diverse clinical trials across infectious diseases, neurology, oncology, cardiology, and respiratory medicine. His contributions extend to both academia and industry, including collaborative work with prestigious global institutions. Dr. Saeed’s scholarly work encompasses book chapters and peer-reviewed publications that highlight his dedication to evidence-based medicine and medical education. Beyond his scientific contributions, he is recognized for mentoring young professionals and promoting ethical research practices. His blend of clinical acumen, research excellence, and leadership has positioned him as a key figure in modern translational research and therapeutic development.

Profile

ORCID

Education

Dr. Muhammad Saeed’s academic journey reflects a commitment to excellence and lifelong learning. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow Medical College, University of Karachi, laying the groundwork for his career in clinical medicine and research. His early training emphasized core competencies in surgery and internal medicine, which provided him with strong clinical insights that continue to inform his research leadership. He later pursued advanced studies at Johns Hopkins University, where he completed a Master of Science, equipping him with rigorous training in epidemiology, clinical trial design, and evidence-based research methodologies. His education also includes formative years at Habib Public School in Karachi, where he achieved GCE O’ Levels under the University of Cambridge Local Examination Syndicate. This broad educational foundation, spanning global institutions of repute, has allowed him to integrate strong clinical skills with research innovation, shaping his role as a physician-scientist and educator.

Experience

Dr. Muhammad Saeed’s professional experience spans diverse roles in clinical medicine and research. He began his medical career as a resident physician at Civil Hospital Karachi, training in surgery and medicine. His early exposure to hospital-based care was complemented by research responsibilities at Aga Khan University Hospital, where he worked as a Clinical Research Associate on infectious diseases and public health projects. Transitioning to the United States, he held leadership positions at Advanced Clinical Research Associates in Plano, HRMD Research in Dallas, and later Dallas Regional Medical Center and PRX Research in Mesquite, where he currently serves as Clinical Research Director. In these roles, he has overseen numerous multicenter, international clinical trials across therapeutic areas including oncology, neurology, cardiology, infectious diseases, and COVID-19. His leadership ensures regulatory compliance, patient safety, and high-quality outcomes in research. This experience highlights his ability to integrate patient care, research innovation, and administrative excellence.

Awards and Honors

Dr. Muhammad Saeed has been recognized for his outstanding contributions to clinical research, academic medicine, and patient-centered healthcare. His work in infectious disease research and clinical trial leadership has earned him respect among peers in both academic and industry settings. He has collaborated with leading researchers globally, resulting in publications and recognition in international medical circles. His co-authored book, What I Wish I Knew Before Medical School, reflects his dedication to mentoring and educating the next generation of healthcare professionals, further enhancing his academic reputation. His chapter contributions to the International Encyclopedia of Public Health positioned him among notable voices in global health. Over his career, he has been acknowledged for his role in advancing therapeutic development, particularly during the COVID-19 pandemic through multiple high-impact trials. These honors reflect not only his scholarly achievements but also his contributions to improving medical care through innovative and ethical clinical research practices

Research Focus

Dr. Muhammad Saeed’s research focus lies at the intersection of clinical innovation and public health. His academic research has addressed infectious diseases, including typhoid detection in children and diabetes risk factors in underserved communities. In industry, he has spearheaded large-scale multicenter clinical trials across diverse therapeutic areas, including cardiology, oncology, neurology, respiratory diseases, and COVID-19. His work emphasizes patient safety, treatment efficacy, and advancing therapeutic options for conditions with high unmet medical needs. He has been deeply involved in clinical trial design, implementation, and analysis, ensuring robust outcomes that translate into better clinical practices. Beyond therapeutic innovation, Dr. Saeed’s work reflects a commitment to advancing methodologies for early disease detection, novel biomarkers, stem-cell based therapies, and cutting-edge treatments for neurodegenerative and chronic illnesses. His research philosophy integrates medical rigor, ethical practice, and translational application, aiming to bring scientific discovery from the research bench directly to patient care with lasting global impact.

 

Publications

Title: Impacts of Ambient Temperatures on Pediatric Anemia in Sub-Saharan Africa: A Regional Ecological Study
Year: 2025

Title: Evaluation of the Potential Of Rejuveinix Plus Dexamethasone Against Sepsis
Year: 2022

Title: Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
Year: 2022

Title: Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis
Year: 2020

Title: Clinical characteristics, management and outcome of major pulmonary embolism: an experience from a tertiary care center in Pakistan
Year: 2009

Conclusion

Dr. Muhammad  Saeed is a distinguished physician-scientist whose career blends clinical expertise, research leadership, and academic scholarship, with a strong focus on advancing therapeutic innovation, improving patient care, and mentoring future medical professionals through global collaborations and ethical research excellence.

Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Jesus Avila | Tauopathies | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Jesus Avila | Tauopathies | Best Researcher Award

Dr. Jesus Avila is a distinguished cognitive scientist and Professor ad honorem at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), Spain. He obtained his degree in Chemistry and PhD in Molecular Biology from Universidad Complutense Madrid, focusing on RNA polymerase in B. subtilis. His postdoctoral research at NIH, USA, centered on the SV40 virus. Throughout his prolific career, Dr. Avila has made groundbreaking contributions to understanding the neuronal cytoskeleton, particularly tau protein, its role in Alzheimer’s disease, and tauopathies. With over 694 published journal articles, 33 books, 4 patents, and collaborations across the USA, France, UK, Germany, and Spain, his work is internationally recognized. He serves on editorial boards of prestigious journals including EMBO J, FEBS Letters, Neuroscience, and Journal of Alzheimer’s Disease (Deputy Editor). Dr. Avila is a member of EMBO, Academia Europaea, AAAS, and Royal Academies of Sciences and Medicine of Spain.

Professional Profile

Education

Dr. Jesus Avila pursued his higher education at Universidad Complutense Madrid (UCM), earning a degree in Chemistry. He further specialized by completing a PhD in Molecular Biology at UCM, where his research focused on the B. subtilis RNA polymerase system. This solid foundation in molecular biology provided him with the expertise to investigate complex neurobiological mechanisms. He then advanced his academic career with postdoctoral training at the National Institutes of Health (NIH) in Bethesda, Maryland, USA, where he studied the SV40 virus—a crucial step that introduced him to advanced molecular virology and neurobiology techniques. This diverse academic background enabled him to establish a globally recognized research portfolio in neurodegeneration, particularly tau protein’s role in neuronal function and dysfunction.

Experience

Dr. Avila has an illustrious career spanning several decades at the Centro de Biologia Molecular Severo Ochoa (CBM-CSIC), where he has led pioneering research into the neuronal cytoskeleton, tau protein dysfunction, and neurodegenerative diseases. His early research at NIH on SV40 virus provided him with robust molecular expertise, which he translated into comprehensive studies on tauopathies and Alzheimer’s disease upon returning to Spain. Dr. Avila has successfully led over 30 major research projects, consulted on 8 industry collaborations, and published 694 peer-reviewed articles. His work includes the authorship of 33 books and the filing of 4 patents. Through sustained collaborations with global leaders in neuroscience from the USA, France, UK, Germany, and Spain, he has significantly advanced the understanding of aging and cognitive decline. His academic leadership and editorial roles underscore his vast experience in guiding both research and scientific discourse.

Research Interests

Dr. Avila’s research primarily investigates the neuronal cytoskeleton, with a central focus on tau protein and its role in neurodegeneration. Beginning with tau’s structural function in neurons, his work has expanded to explore how tau dysfunction contributes to Alzheimer’s disease and other tauopathies. Utilizing molecular and cellular approaches, including advanced mouse models, he has dissected the pathological mechanisms linking tau pathology to cognitive decline. Recognizing aging as the principal risk factor for Alzheimer’s disease, his current investigations target neuronal rejuvenation strategies to mitigate age-associated neurodegeneration. His integrative approach combines molecular biology, neurogenetics, and translational models, contributing significantly to the understanding of disease progression and potential therapeutic interventions. Through over 694 publications, 33 books, multiple patents, and international collaborations, Dr. Avila has substantially advanced the field of cognitive neuroscience, particularly in understanding and combating tau-mediated cognitive disorders.

Awards

Dr. Avila’s exemplary contributions have earned him numerous prestigious honors. He is an elected member of EMBO (European Molecular Biology Organization), Academia Europaea, AAAS (American Association for the Advancement of Science), and both the Royal Academies of Sciences and Medicine of Spain—testament to his global recognition and scientific excellence. His editorial appointments with highly respected journals such as EMBO J, FEBS Letters, Neuroscience, and his role as Deputy Editor of the Journal of Alzheimer’s Disease further validate his authority in cognitive and neurodegenerative research. His citation index surpasses 100 on Scopus, reflecting the significant influence of his work. His extensive collaborations with leading international research teams highlight his status as a respected leader in the global scientific community. The combination of his research excellence, mentorship, and leadership has positioned him as one of the foremost experts in cognitive science and neurobiology.

Conclusion

Dr. Jesus Avila’s distinguished career combines pioneering research on tau protein and Alzheimer’s disease, extensive international collaborations, over 694 publications, leadership roles in major journals, multiple prestigious memberships, and an unwavering focus on neuronal rejuvenation strategies, positioning him as a world-leading cognitive scientist whose work continues to advance global understanding of neurodegeneration.

 Publications

  • Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer’s disease

    Experimental Neurology
    2025 | Journal article
    DOI: 10.1016/j.expneurol.2024.115049

    EID:

    2-s2.0-85208758184

    Part ofISSN: 10902430 00144886
    CONTRIBUTORS: Merino-Serrais, P.; Soria, J.M.; Arrabal, C.A.; Ortigado-López, A.; Esparza, M.Á.G.; Muñoz, A.; Hernández, F.; Ávila, J.; DeFelipe, J.; León-Espinosa, G.

  • Retrotransposon Protein L1 ORF1p Expression in Aging Central Nervous System

    International Journal of Molecular Sciences
    2025-05-04 | Journal article
    DOI: 10.3390/ijms26094368
    CONTRIBUTORS: Laura Vallés-Saiz; Aaron Abdelkader-Guillén; Jesús Ávila; Félix Hernández

  • Shapeshifter W-Tau Peptide Inhibits Tau Aggregation and Disintegrates Paired Helical Filaments

    Biochemistry
    2025-04-15 | Journal article
    DOI: 10.1021/acs.biochem.4c00809
    CONTRIBUTORS: Indalo Domene-Serrano; Raquel Cuadros; Vega García-Escudero; Francisco Vallejo-Bedia; Ismael Santa-María; Laura Vallés-Saiz; Félix Hernandez; Jesús Avila

  • Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery

    ACS Omega
    2025-04-08 | Journal article
    DOI: 10.1021/acsomega.4c10849
    CONTRIBUTORS: Alejandro Anton-Fernandez; Indalo Domene-Serrano; Raquel Cuadros; Rocio Peinado-Cahuchola; Margarita Sanchez-Pece; Felix Hernandez; Jesus Avila

  • Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer\’s disease

    Progress In Neurobiology
    2025-04-01 | Journal article | Author
    DOI: 10.1016/j.pneurobio.2025.102743

    SOURCE-WORK-ID:

    CSIC-GB950859

    EID:

    2-s2.0-85219079150

    Part ofISSN: 0301-0082
    CONTRIBUTORS: Alejandro Anton-Fernandez; Ruiz de Alegría, Álvaro; Mariscal-Casero, Ana; Roldán-Lázaro, Marta; Peinado-Cauchola, Rocío; Jesus Avila; Felix Hernandez

  • Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

    Aging Cell
    2025-01 | Journal article
    DOI: 10.1111/acel.14365
    CONTRIBUTORS: Alejandro Antón‐Fernández; Rocío Peinado Cauchola; Félix Hernández; Jesús Ávila

  • Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3

    eBioMedicine
    2024 | Journal article
    DOI: 10.1016/j.ebiom.2023.104953

    EID:

    2-s2.0-85181837483

    Part ofISSN: 23523964
    CONTRIBUTORS: Ruiz-Gabarre, D.; Vallés-Saiz, L.; Carnero-Espejo, A.; Ferrer, I.; Hernández, F.; Garcia-Escudero, R.; Ávila, J.; García-Escudero, V.

  • Involvement of the cellular prion protein in seeding and spreading of sarkosyl-derived fractions of Alzheimer´s disease in Prnp mutant mice and in the P301S transgenic tauopathy mice model

    bioRxiv
    2024 | Other
    DOI: 10.1101/2024.01.20.576414

    EID:

    2-s2.0-85184321414

    Part of ISSN: 26928205
    CONTRIBUTORS: Sala-Jarque, J.; Gil, V.; Andrés-Benito, P.; Lidón, L.; Yanac-Huertas, R.E.; López-León, C.F.; Hernández, F.; Ávila, J.; Lanciego, J.L.; Soriano, J. et al.

Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Assos. Prof. Dr. Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Dr. Konrad Talbot is a distinguished neuroscientist and Associate Professor at Loma Linda University School of Medicine, serving in the Departments of Neurosurgery, Pathology & Human Anatomy, and Basic Sciences since 2018. He specializes in investigating the pathogenesis and treatment of neurodegenerative and psychiatric disorders, particularly focusing on brain insulin resistance in Alzheimer’s and Parkinson’s diseases. With a Ph.D. in Physiological Psychology from UCLA and extensive postdoctoral training at the University of Pennsylvania, Dr. Talbot has held faculty and research positions at leading institutions such as Cedars-Sinai, UCLA, and UPenn. He is a highly cited researcher (H-index: 34, 9341 citations), with significant NIH and international grant support. He also serves as an editorial board member, reviewer, and invited speaker at global conferences. His work has influenced both fundamental neuroscience and the development of therapeutic strategies for brain diseases.

Profile

🎓 Education

Dr. Konrad Talbot completed his undergraduate (B.A.), master’s (M.A.), and doctoral (Ph.D.) degrees in Psychology with a specialization in Physiological Psychology at the University of California, Los Angeles (UCLA). His academic path reflects a deep commitment to understanding the biological underpinnings of behavior and brain function. He also received formal teaching certification from UCLA’s Instructor Development Program in 1992. His postdoctoral training included pivotal roles at the University of Pennsylvania’s Department of Pathology and Laboratory Medicine and the Center for Neurodegenerative Disease Research (1997–2001), where he developed expertise in brain autopsy and pathology. He furthered his technical capabilities through advanced training in quantitative fluorescence microscopy at Mount Desert Island Biological Laboratory in 2007. His broad educational background forms a strong foundation for his interdisciplinary research and teaching roles across psychology, neurobiology, pathology, and medical sciences.

🧪 Experience

Dr. Talbot’s academic journey spans over three decades, beginning as an Assistant Professor at Mount St. Mary’s College and St. Olaf College, where he taught psychology and mentored numerous students. He transitioned into intensive research roles at the University of Pennsylvania (UPenn) from 1997 to 2012, ascending from postdoctoral investigator to senior research investigator and research faculty. He later held associate research professorships at Cedars-Sinai Medical Center and UCLA. Since 2018, he has served as Associate Professor at Loma Linda University. Dr. Talbot has authored influential studies on brain insulin resistance, taught neuroanatomy to medical residents, supervised postdoctoral and undergraduate research projects, and served in various academic leadership and committee roles. In addition to his research and teaching, he has contributed editorial expertise to high-impact journals and consulted on landmark neuroanatomical atlases. His career reflects a blend of teaching excellence, pioneering research, and interdisciplinary leadership.

🏅 Awards and Honors

Dr. Talbot’s contributions have been widely recognized through prestigious awards and honors. In 2003, he received the T.L.L. Temple Foundation Discovery Award from the Alzheimer’s Association for his groundbreaking work on brain insulin resistance. He was honored as a co-dedicatee of the influential neuroscience text The Mouse Brain in Stereotaxic Coordinates (2008 edition), highlighting his impact on anatomical brain mapping. In 2020, he was inducted into the Sigma Chi Scientific Research Honor Society. His professional affiliations include long-standing memberships with the Society for Neuroscience, Alzheimer Research Forum, Schizophrenia Research Forum, and ISTAART (International Society to Advance Alzheimer Research and Treatment). He has played leadership roles in organizing major scientific conferences, chaired institutional committees, and served on advisory panels. His editorial contributions and invited lectures worldwide further underscore the scientific community’s high regard for his research excellence and thought leadership.

🔬 Research Focus

Dr. Talbot’s research centers on identifying and targeting mechanisms underlying neurodegenerative and psychiatric diseases, with a special emphasis on insulin resistance in the brain. He has pioneered investigations showing that brain insulin resistance plays a critical role in Alzheimer’s and Parkinson’s disease pathogenesis. His NIH-funded work explores the therapeutic potential of incretin receptor agonists—an emerging class of antidiabetics—in reducing brain insulin resistance and improving cognitive function. His collaborative projects with institutions like CUNY, UCLA, and the University of Washington focus on both human brain tissue analysis and preclinical models. Past research includes the molecular biology of schizophrenia, especially dysbindin-related pathways. He holds a U.S. patent application on methods for treating brain insulin resistance, signaling the translational potential of his findings. Dr. Talbot’s research integrates neuropharmacology, pathology, neuroanatomy, and clinical neuroscience, aiming to develop disease-modifying treatments that can halt or reverse progression in cognitive and psychiatric disorders.

✅ Conclusion

Dr. Konrad Talbot is an accomplished neuroscientist whose multidisciplinary work in brain insulin resistance has significantly advanced understanding and treatment approaches for Alzheimer’s and Parkinson’s diseases, blending rigorous research, impactful teaching, and translational innovation.

Publications

Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Profile

🎓 Education

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

🧪 Experience

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

🔬 Research Focus

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

✅ Conclusion

Assist. Prof. Dr. Mai O. Kadry is a distinguished biochemistry researcher whose work bridges advanced molecular biology and therapeutic innovation. With expertise in nanotoxicity, oxidative injury, and cancer therapy, she contributes significantly to biomedical science through impactful research and academic leadership. Her training in cutting-edge techniques and her focus on translational medicine position her at the forefront of scientific discovery. Dr. Kadry’s dedication to improving healthcare through targeted therapies and her commitment to academic excellence make her a valuable asset to the scientific community. Her career reflects passion, innovation, and a relentless pursuit of better treatment solutions.

 

Publications

  • Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0111
    CONTRIBUTORS: Mai O Kadry; Abdel-Hamid Z Abdel Hamid; Rehab M Abdel-Megeed

  • Fischer’s oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0117
    CONTRIBUTORS: Mai O Kadry; Hanaa Mahmoud Al

  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.1080/20565623.2024.2422791
    CONTRIBUTORS: Mai O. Kadry; Rehab M. Abdel-Megee

Nuo Yu | Radiomics | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Nuo Yu | Radiomics | Best Researcher Award

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ,China

Nuo Yu is a Ph.D. candidate at the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences, specializing in radiation oncology with a focus on esophageal squamous cell carcinoma (ESCC). His research primarily explores innovative chemoradiotherapy regimens to improve treatment outcomes for patients with locally advanced ESCC.

Yu has contributed to several peer-reviewed publications in SCI-indexed journals. Notably, he co-authored a study titled “Conversion Chemoradiotherapy Combined with Nab-Paclitaxel Plus Cisplatin in Patients with Locally Advanced Borderline-Resectable or Unresectable Esophageal Squamous Cell Carcinoma: A Phase I/II Prospective Cohort Study,” published in Strahlentherapie und Onkologie in August 2024. This research evaluated the efficacy and safety of a novel chemoradiotherapy regimen, demonstrating promising results in locoregional control and overall survival rates.

In March 2023, Yu co-authored another significant study, “Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study,” published in Current Cancer Drug Targets. This research focused on treatment strategies for elderly patients with ESCC, highlighting the potential benefits of combining chemoradiotherapy with nimotuzumab.

Yu’s work has been recognized at international conferences, including presentations at the American Society for Radiation Oncology (ASTRO), the Federation of Asian Organizations for Radiation Oncology (FARO), and the Korean Society for Radiation Oncology (KOSRO). These engagements underscore his active participation in the global radiation oncology community and his commitment to advancing cancer treatment research.

While still in the early stages of his career, Yu’s focused research on ESCC and his contributions to the field of radiation oncology position him as a promising candidate for the Best Researcher Award. Continued efforts to expand his research scope, increase publication impact, and assume leadership roles in larger-scale studies will further strengthen his candidacy.

Profile

Scientific Publications